Corbion N.V. — M&A Activity 2018

Feb 14, 2018

Corbion nv Piet Heinkade 127 • 1019 GM Amsterdam PO Box 349 • 1000 AH Amsterdam The Netherlands

T +31 (0)20 590 6911 press@corbion.com www.corbion.com

PRESS RELEASE

DATE 14 February 2018

Corbion in discussions to acquire Bunge's stake in SB Renewable Oils joint venture

Corbion nv (Euronext Amsterdam: CRBN) ("Corbion") announces it is in discussions with Bunge Limited (NYSE: BG) ("Bunge") regarding the potential acquisition by Corbion of Bunge's stake in the SB Renewable Oils joint venture. Today, Bunge has also disclosed these discussions, as part of a strategic update alongside the release of its year-end 2017 financial results.

Corbion and Bunge are 50.1%/49.9% partners in SB Renewable Oils, a joint venture that operates a facility in Brazil, specializing in the production of algae ingredients, such as Omega 3 rich oil, for aquaculture and animal feed.

While the discussions are constructive, it is uncertain if and when they will lead to an agreement.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For more information, please contact:

Analysts and investors: Jeroen van Harten, Director Investor Relations +31 (0)20 590 6293, +31(0)6 21 577 086

Press: Tanno Massar, Senior Director Corporate Communications +31 (0)20 590 6325, +31 (0)6 11 589 121

Background information:

Corbion is the global market leader in lactic acid, lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. We develop sustainable ingredient solutions to improve the quality of life for people today and for future generations. For over 100 years, we have been uncompromising in our commitment to safety, quality, innovation and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting-edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, animal nutrition, pharmaceuticals, medical devices, and bioplastics. In 2016, Corbion generated annual sales of € 911.3 million and had a workforce of 1,684 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com